Prevention of postoperative nausea and vomiting (PONV) with single oral dose of dolasetron, compared to single dose of intravenous droperidol and a combination of both substances in patients undergoing hysterectomy. Objective;Prophylaxe von postoperativer ubelkeit und erbrechen nach hysterektomie mit oralem dolasetron, intravenosem dehydrobenzperidol (DHB) oder einer kombination beider substanzen. Eine placebokontrollierte untersuchung

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 34, Issue 6, 1999, Pages 340-344

  Triem, J G ^b   Piper, Swen N ^a   Maleck, W H ^b   Schenck, A ^b   Schmidt, C C ^b   Boldt, J ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b NONE

Author keywords

Dolasetron; Droperidol; Vomiting in gynaecologic surgery

Indexed keywords

DOLASETRON MESILATE; DROPERIDOL; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON; TROPISETRON;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; VOMITING;

ANTIEMETICS; DROPERIDOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYSTERECTOMY; INDOLES; METOCLOPRAMIDE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; QUINOLIZINES;

EID: 0032811577     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-9974     Document Type: Article

References (29)

1. 3-Rezeptorblockern. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1996; 31: 200-204
2. Desilva PHDP, Darvish AA, McDonald SM, Cronin MK, Clark K: The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. Anesth. Analg. 1995; 81: 139-143
3. Saur P, Mühr C, Kazmaier S, Neumann P, Buhre W: Prophylaxe der postoperativen Übelkeit und des Erbrechens mittels Einmal-und Repetitionsgabe von Ondansetron - Literaturübersicht über verschiedene Applikationsformen. Anesthesiol. Reanimat. 1996; 21: 131-135
4. Ali-Melkkilä T, Kanto J, Katevuo R: Tropisetron and metoclopramide in the prevention of postoperative nausea and vomiting. Anaesthesia 1995; 51: 232-235
5. Andrews PRL: Physiology and nausea and vomiting. Br. J. Anaesth. 1992; 69: 2S-19S
6. Apfel CC, Griem CA, Haubitz I, Goepfert C, Sefrin P, Roewer N: The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol. Scand. 1998; 42: 502-509
7. Krüper S, Patzke M, Mohr OE, Jantzen JP: Übelkeit und Erbrechen nach gynäkologischen Laparoskopien: Propofol/Sufentanil versus Thiopental/Isofluran/Sufentanil. Anästh. Intensivmed. 1997; 38: 292-295
8. Guggenberger H, Fritz T, Guggenberger E, Warth H, Wittkowski KM, Heuser D: Beschwerden in der postoperativen Phase in Abhängigkeit vom Narkosemittel. Anaesthesist 1988; 37: 746-751
9. Gratz I, Allen E, Afshar M, Joslyn AF, Buxbaum J, Prilliman B: The effects of the menstrual cycle of the incidence of emesis and efficacy of ondansetron. Anesth. Analg. 1996; 83: 565-569
10. Fragneto RY: Antiemetics for obstetric and gynecological procedures. Curr. Opin. Anaesth. 1998; 11: 275-281
11. Raber M, Tryba M: Übelkeit und Erbrechen in der postoperativen Phase: Medikamentöse Prophylaxe und Therapie mit etablierten Substanzen beim Erwachsenen. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1997; 32: 623-626
12. Kapur PA: The big "little problem". Anesth. Analg. 1991; 73: 243-245
13. Hennes HJ: Prophylaxe und Behandlung der postoperativen Übelkeit und des postoperativen Erbrechens mit Tropisetron. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1997; 32: 628-631
14. Raatz U: Die Modifikation des White-Tests bei großen Stichproben. Biometrische Zeitschrift 1966; 8: 42-54
15. Korttila K, Clergue F, Leeser J, Feiss P, Olthoff D, Payeur-Michel C, Wessel P, Navé S, Hahne W: Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Acta Anaesthesiol. Scand. 1997; 41: 914-922
16. Balfour JA, Goa KL: Dolasetron. A Review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. Drugs 1997; 54: 273-298
17. 3 receptor antagonist. Drug. Metab. Dispos. 1995; 23: 806-812
18. Diemunsch P, Leeser J, Feiss P, D'Hollander A, Bradburn BG, Paxton D, Whitmore J, Panouillot P, Navé S, Brown RA, Hahne WF: Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting. Can. J. Anaesth. 1997; 44: 173-181
19. Chevallier B, Cappelaere P, Splinter T, Fabbro M, Wendling JL, Cals L, Catimel G, Giovannini M, Khayat D, Bastis P, Claverie N: A double-blind, multicentre comparison of intravenous dolasteron mesilate and metoclopraminde in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. Support. Care Cancer 1997; 5: 22-30
20. Diemunsch P, D'Hollander A, Paxton L, Schoeffler P, Wessel P, Navé S, Brown RA, Hahne WF: Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery. J. Clin. Anesth. 1997; 9: 365-373
21. Warringer CB, Knox D, Belo S, Cole S, Finnegan B, Perreault L, Kronberg J, Hudson R, Plourde G, Murphy L, Tetrault JP, Duval D, Derkzo C, Juneau M, Dempsey E, McKenzie K, Keays S: Prophylactic oral dolasetron mesylate reduces postoperative nausea and vomiting following abdominal hysterectomy. Anesthesiology. 1995; 83: A312
22. Philip B, McLeskey C, Chelly J, McKenzie, Kovac A, Whitemore J, Brown R: Evaluation of dolasetron mesylate needed to prevent postoperative nausea and vomiting. Anesthesiology 1996; 85: A37
23. Warringer CB, Knox D, Belo S, Cole C, Finnegan B, Perreault L: Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy. Can. J. Anaesth. 1997; 44: 1167-1173
24. Raber M, Tryba M, Michels R, Zimmer C, Kulka PJ, Zenz M: Beeinflußt der Applikationszeitpunkt die Wirksamkeit von Dehydrobenzperidol (DHB) zur Prophylaxe von Übelkeit und Erbrechen in der postoperativen Phase (PONV)? Anesthesist 1995; 44 (Suppl. 2): S501
25. Fassoulaki A, Galanaki E: The antiemetic effect of droperidol: is it dose dependent? Acta Anaesthesiol. Belg. 1989; 40: 179-182
26. Alexander R, Lovell AT, Seingry D, Jones RM: Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995; 50: 1086-1088
27. Fortney J, Gan TJ, Graczyk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrilo S, Glass PSA, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR: A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antimetics for elective outpatient surgical produres. Anesth. Analg. 1998; 86: 731-738
28. Fujii Y, Toyooka H, Tanaka H: Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol. Anesth. Analg. 1998; 86: 613-616
29. Rote Liste 1998: Arzneimittelverzeichnis des Bundesverbandes der Pharmazeutischen Industrie e.V. (BPI), des Verbandes Forschender Arzneimittelhersteller e.V. (VFA), des Bundesfachverbandes der Arzneimittel-Hersteller e.V. (BAH und des Verbandes aktiver Pharmaunternehmen e.V. (VAP). Rote Liste Service GmbH (Hrsg.). Editio Cantor Verlag, Aulendorf